Characterization of C1 Inhibitor-Ta
Authors:
- Alvin E. DavisADAlvin E. Davis
Open Access
- 1 September 1996
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (39) , 24307-24312
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.Journal of Clinical Investigation, 1995
- C1 inhibitor hinge region mutations produce dysfunction by different mechanismsNature Genetics, 1992
- A Single Base Deletion from the C1-Inhibitor Gene Causes Type I-Hereditary Angio-OedemaHuman Heredity, 1992
- Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site.Proceedings of the National Academy of Sciences, 1990
- Antithrombin Cambridge, 384 Ala to Pro: A new variant identified using the polymerase chain reactionFEBS Letters, 1989
- Ovalbumin and angiotensinogen lack serpin S–R conformational changeBiochemical Journal, 1989
- Antithrombin-III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease reactivityBlood, 1988
- A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.Journal of Clinical Investigation, 1988
- Dysfunctional C1̅-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 ‘reactive centre’ (Arg444→His) mutationBiochemical Journal, 1988
- C1 Inhibitor and Hereditary Angioneurotic EdemaAnnual Review of Immunology, 1988